Now accepting nominations.
Who is eligible?
Local women from both the public and private sector who have demonstrated professional excellence and leadership in their
careers and community service.
What are the criteria?
We're looking for women who:
• are influential in their company or industry.
• have a solid reputation within their company or industry based on their experience, integrity and leadership.
• have a track record of accomplishment.
How do I nominate someone?
Complete and submit the online nomination form.
What is the deadline?
September 20, 2013
Can I contact you to make sure my nomination was received?
Yes, you can email pjohns@ibj.com.
When does the section publish?
November 4, 2013
Can I see examples of who's been honored in previous years?
Yes, click here to see a list
of previous honorees. Honorees from 2008, 2009, 2010, 2011 and 2012 are not eligible for nomination in 2013.

















Three Magi
Cats out of the bag. The object of the game is to get acquired. That means the company has no idea how to grow beyond a certain point. Email is a 1990s technology. I have laughed at this company since day one. Such a small bit player. If it was anywhere but here, it wouldn't be newsworthy.
Esther, Indy has passed Chicago in the local government corruption arena. Don't downgrade us. We're No. 1 in the Midwest.
Does the buyer get to keep the recent Accu-Chek J.D. Power award? Be careful, those Swiss cannot be trusted. Last June they pimped Mayor Ballard and former Governor Daniels at a media op, announcing plans to invest "$300 million at its Indianapolis headquarters, creating up to 100 new jobs by 2017," only to turn around and close the Roche Nutley, NJ facility and eliminate 1000 jobs there later the same week. It seems that healthcare can be innovated only as long as money is to be made. Right now Roche seems to have big eyes for China: there are many Chinese in China and potential billions in Swiss francs! Since Roche is having difficulty with US insurance companies swallowing the bill for overpriced cancer drugs (with debatable efficacy) why not sell insurance to the Chinese and market the drugs to them there? There is a name for these sort of business practices however proper decorum precludes it use in this forum.
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.